Clinical Impact of Molecular Imaging
Clinical Impact of Molecular Imaging
Tuesday, Nov. 30, 10:30 AM - 12:00 PM
Speakers are discussing the clinical and practice implications of the increased use of PET/CT in clinical decision-making and sharing information about opportunities for nuclear medicine technologists in the Clinical Trials Network.
The speakers are:
Tuesday, Nov. 30, 10:30 AM - 12:00 PM
Speakers are discussing the clinical and practice implications of the increased use of PET/CT in clinical decision-making and sharing information about opportunities for nuclear medicine technologists in the Clinical Trials Network.
The speakers are:
- Charles T. Stanley, imaging manager, 3D/CT/MRI lab, University of Virginia in Charlottesville, Va.;
- David Gilmore, operations manager, imaging and cardiac testing, Massachusetts General Hospital in Boston.